Nasdaq · Technology
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
As-reported financials and recent SEC filings for KEWAUNEE SCIENTIFIC CORP /DE/, latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$282.0M
Net income
$9.6M
Net margin
3.4%
Diluted EPS
$3.22
ROE
12.5%
P/E (TTM)
9.6×
Market cap
$102.7M
Debt / equity
0.2×
Income statement (as reported)
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $282.0M | $240.5M | $203.8M | $219.5M | $168.9M |
| Gross profit | $80.4M | $68.9M | $52.1M | $35.6M | $24.2M |
| Operating income | $16.7M | $17.8M | $18.3M | $5.4M | $-2.6M |
| Net income | $9.6M | $11.4M | $18.8M | $738,000 | $-6.1M |
| Diluted EPS | $3.22 | $3.83 | $6.38 | $0.25 | $-2.20 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
10-K2026-06-26
View on EDGAR →42026-06-25
View on EDGAR →42026-06-25
View on EDGAR →42026-06-25
View on EDGAR →42026-06-25
View on EDGAR →42026-06-25
View on EDGAR →42026-06-25
View on EDGAR →8-K2026-06-23
View on EDGAR →Go deeper on KEQU
Search KEWAUNEE SCIENTIFIC CORP /DE/’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.